Glaxo Smithkline
- All
- News
- Videos
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
Partial Relief From High Court for Wockhardt, Glaxo & Griffon
Delhi High Court on Friday stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
-
Supreme Court asks Centre to investigate 'unauthorised' clinical trials
The Supreme Court today issued notice to the Centre on a Public Interest Litigation (PIL), which alleges that pharma company Glaxo Smithkline had conducted unauthorised trials of its vaccine on tribal girls.
-
A cheap anti-malarial being developed
GlaxoSmithKline are on the verge of developing a cheap anti-malarial drug, LAPDAP, in collaboration with the World Health Organisation (WHO), for use in the under-developed countries. Malaria is an infectious disease caused by the female anopheles mosquito, and is still rampant in Africa and India. Though it is eminently treatable, the medicines m...
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
Partial Relief From High Court for Wockhardt, Glaxo & Griffon
Delhi High Court on Friday stayed the the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
-
Supreme Court asks Centre to investigate 'unauthorised' clinical trials
The Supreme Court today issued notice to the Centre on a Public Interest Litigation (PIL), which alleges that pharma company Glaxo Smithkline had conducted unauthorised trials of its vaccine on tribal girls.
-
A cheap anti-malarial being developed
GlaxoSmithKline are on the verge of developing a cheap anti-malarial drug, LAPDAP, in collaboration with the World Health Organisation (WHO), for use in the under-developed countries. Malaria is an infectious disease caused by the female anopheles mosquito, and is still rampant in Africa and India. Though it is eminently treatable, the medicines m...
